CHAMPIONS ONCOLOGY, INC. 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Principal Market or Markets Our shares of common stock are currently quoted on the Nasdaq Capital Market under the symbol “CSBR.” Our common stock commenced trading on the Nasdaq Capital Market on August 21, 2015. Prior to such date, our shares of common stock were traded over-the-counter and quoted on the OTCQB Marketplace. The table below sets forth the high and low bid prices of our common stock, as reported on Nasdaq for the periods shown: High Low Fiscal Year Ended April 30, 2022: First quarter $ 11.25 $ 8.45 Second quarter 11.00 9.23 Third quarter 10.38 7.60 Fourth quarter 8.93 7.06 High Low Fiscal Year Ended April 30, 2021: First quarter $ 10.89 $ 7.46 Second quarter 9.97 7.05 Third quarter 13.45 8.30 Fourth quarter 14.68 10.06 Approximate Number of Holders of Common Stock As of July 20, 2022 there were approximately 1,900 record holders of the Company’s common stock. Dividends Holders of our common stock are entitled to receive such dividends as may be declared by our Board of Directors. No dividends have been declared or paid with respect to our common stock and no dividends are anticipated to be paid in the foreseeable future. Any future decisions as to the payment of dividends will be at the discretion of our Board of Directors, subject to applicable law. Recent Sales by the Company of Unregistered Securities None. 15 Repurchases of Securities None. Use of Proceeds None. Item 6. Reserved